Enovis Corporation (ENOV) Guidance & Earnings Results

On 2026-08-06 Enovis Corporation reaffirmed guidance: "Revenue $2.31-2.37B, adjusted EBITDA $425-435M, adjusted EPS $3.52-3.73, FCF conversion…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-07-03 · read by EquiReason

ENOVEnovis CorporationFollow ENOV — free

Medical Devices · Healthcare

—

Price chart with a free account

Market cap: 1.2B
P/E TTM: —
Dividend yield: —
52-week: —
Next earnings: 5 Nov, in 12 days

What management guided

each earnings 8-K · figures checked against the filing text

Release	Direction	What they said
6 Aug 26	Reaffirmed	Revenue $2.31-2.37B, adjusted EBITDA $425-435M, adjusted EPS $3.52-3.73, FCF conversion 25%+ · full year
7 May 26	Reaffirmed	Revenue $2.31-2.37B, adjusted EBITDA $425-435M, adjusted EPS $3.52-3.73, FCF conversion 25%+ · full year
26 Feb 26	Raised	FY2026 revenue $2.31-2.37B, adj. EBITDA $425-435M, adj. EPS $3.52-3.73 · full year
6 Nov 25	Raised	Adjusted EBITDA $395-405M (from $392-402M), Adjusted EPS $3.10-$3.25 (from $3.05-$3.20) · full year
7 Aug 25	Raised	FY25 revenue raised to $2.245-2.275B from $2.220-2.250B; adjusted EBITDA raised to $392-402M from $385-395M; adjusted EPS raised to $3.05-3.20 from $2.95-3.10 · full year

Enovis Corporation — questions

What guidance did Enovis Corporation give?: On 2026-08-06: "Revenue $2.31-2.37B, adjusted EBITDA $425-435M, adjusted EPS $3.52-3.73, FCF conversion 25%+"
When does Enovis Corporation report earnings?: Enovis Corporation's next earnings report is expected on 2026-11-05.

Every figure on this page comes from Enovis Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.